Tchaikapharma High Quality Medicines AD (BUL:THQM)
Bulgaria flag Bulgaria · Delayed Price · Currency is BGN
17.60
0.00 (0.00%)
At close: May 8, 2025

BUL:THQM Revenue

Tchaikapharma High Quality Medicines AD had revenue of 16.19M BGN in the quarter ending March 31, 2025, with 21.16% growth. This brings the company's revenue in the last twelve months to 55.97M, up 15.96% year-over-year. In the year 2024, Tchaikapharma High Quality Medicines AD had annual revenue of 53.14M with 9.54% growth.

Revenue (ttm)
55.97M
Revenue Growth
+15.96%
P/S Ratio
28.87
Revenue / Employee
518.22K
Employees
207
Market Cap
1.62B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202453.14M4.63M9.54%
Dec 31, 202348.51M5.37M12.44%
Dec 31, 202243.15M715.00K1.69%
Dec 31, 202142.43M2.33M5.80%
Dec 31, 202040.11M5.38M15.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Shelly Group SE 208.70M
Speedy AD 519.17M
Sopharma AD 2.14B
First Investment Bank AD 418.43M
Eurohold Bulgaria AD 2.79B
M+S Hydraulic AD 144.82M
Smart Organic AD 93.58M
Holding Varna AD 86.75M
Revenue Rankings